4//SEC Filing
Welch David Ryan 4
Accession 0001493152-25-016409
CIK 0001826397other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 7:56 PM ET
Size
17.7 KB
Accession
0001493152-25-016409
Insider Transaction Report
Form 4
Welch David Ryan
Director
Transactions
- Award
Common Shares
2025-05-21$11.79/sh+13,022$153,529→ 97,421 total - Purchase
Common Shares
2024-05-17$129.42/sh+11$1,424→ 97,421 total - Award
Common Shares
2025-09-18$2.37/sh+84,388$200,000→ 97,421 total - Award
Stock Options
2023-09-12+3→ 5 totalExercise: $4050.00Exp: 2028-09-12→ Common Shares (3 underlying)
Holdings
- 5
Stock Options
Exercise: $51300.00Exp: 2027-11-18→ Common Shares (1 underlying) - 5
Stock Options
Exercise: $315000.00Exp: 2026-05-31→ Common Shares (1 underlying)
Footnotes (17)
- [F1]Represents Common Shares granted to the Reporting Person that are restricted and subject to a lockup agreement entered into by the Reporting Person in January 2025. Pursuant to the lockup agreement, the Director may not sell any Common Shares owned by the Reporting Person for one year from January 16, 2025 (subject to the ability to sell shares received by each as the result of an employment agreement at any time).
- [F10]As adjusted for the following: (i) a 1 for 50 reverse split that occurred on October 12, 2023, (ii) a 1 for 100 reverse split that occurred on December 6, 2024, and (iii) a 1 for 9 reverse split that occurred on July 30, 2025. The original grant was 156,876 Stock Options.
- [F11]The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche to be vested on the three-month anniversary of date of grant of September 12, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F12]As adjusted for the following: (i) a 1 for 50 reverse split that occurred on October 12, 2023, (ii) a 1 for 100 reverse split that occurred on December 6, 2024, and (iii) a 1 for 9 reverse split that occurred on July 30, 2025. The original exercise price was $1.14.
- [F13]The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche to be vested on the three-month anniversary of date of grant of November 18, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F14]As adjusted for the following: (i) a 1 for 50 reverse split that occurred on October 12, 2023, (ii) a 1 for 100 reverse split that occurred on December 6, 2024, and (iii) a 1 for 9 reverse split that occurred on July 30, 2025. The original grant was 24,447 Stock Options.
- [F15]As adjusted for the following: (i) a 1 for 50 reverse split that occurred on October 12, 2023, (ii) a 1 for 100 reverse split that occurred on December 6, 2024, and (iii) a 1 for 9 reverse split that occurred on July 30, 2025. The original exercise price was $7.00.
- [F16]The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche to be vested on the three-month anniversary of date of grant of May 31, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F17]As adjusted for the following: (i) a 1 for 50 reverse split that occurred on October 12, 2023, (ii) a 1 for 100 reverse split that occurred on December 6, 2024, and (iii) a 1 for 9 reverse split that occurred on July 30, 2025. The original grant was 24,642 Stock Options.
- [F2]Equals the per share closing price on September 17, 2025.
- [F3]As adjusted for the following: (i) a 1 for 50 reverse split that occurred on October 12, 2023, (ii) a 1 for 100 reverse split that occurred on December 6, 2024, and (iii) a 1 for 9 reverse split that occurred on July 30, 2025.
- [F4]As adjusted for a reverse split that occurred on July 30, 2025. The original grant was 117,206 Common Shares.
- [F5]As adjusted for a reverse split that occurred on July 30, 2025. The original price per share was $1.31.
- [F6]As adjusted for a reverse split that occurred on (i) December 6, 2024 and (ii) July 30, 2025. The original grant was 9,900 Common Shares.
- [F7]As adjusted for a reverse split that occurred on (i) December 6, 2024 and (ii) July 30, 2025. The original price per share was $0.1515.
- [F8]As adjusted for the following: (i) a 1 for 50 reverse split that occurred on October 12, 2023, (ii) a 1 for 100 reverse split that occurred on December 6, 2024, and (iii) a 1 for 9 reverse split that occurred on July 30, 2025. The original exercise price was $0.09.
- [F9]If permitted by the policies of any stock exchange on which the Issuer may be listed from time to time, the stock option may be exercised by means of a "cashless exercise", in which event the Issuer shall issue to the holder the net number of common shares determined based on the formula presented in the exhibit to the stock option certificate.
Documents
Issuer
AGRIFORCE GROWING SYSTEMS LTD.
CIK 0001826397
Entity typeother
Related Parties
1- filerCIK 0001871874
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 7:56 PM ET
- Size
- 17.7 KB